Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026
Source: SeekingAlpha
2025-12-21 22:01:17 ET
...
Read the full article on Seeking Alpha
For further details see:
Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026
Fennec Pharmaceuticals Inc.
NASDAQ: FENC
FENC Trading
9.24% G/L:
$9.58 Last:
94,088 Volume:
$9.29 Open:
FENC Latest News
May 14, 2026 06:30:00 am
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 07, 2026 06:36:00 am
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026April 21, 2026 04:30:00 pm
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual MeetingFENC Stock Data
$217,266,422
14,266,721
89.84%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
Research Triangle Park
